Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
👉 buff.ly/4OGCRch
#HGSOC #Chemoresistance
23.07.2025 10:34 — 👍 0 🔁 0 💬 0 📌 0
Olaparib synergy screen reveals Exemestane induces replication stress in triple-negative breast cancer
➡️ buff.ly/vPDXjxq
#TNBC #PARPi
22.07.2025 09:45 — 👍 0 🔁 0 💬 0 📌 0
🔍 We are looking for papers!
🤝 In conjunction with the recent @EACRnews conference on #ImmunoOncology we have an active call for papers!
📩 Submit your latest research in the field of #CancerImmunology #ImmunoOnc
🖊️ Research Article, Short Report or Method
👉 Find out more details buff.ly/ZDb3rO0
21.07.2025 08:42 — 👍 0 🔁 0 💬 0 📌 0
⏳ There is still time to register and attend!
⚕️EACR Goodbye Flat Biology: ex vivo to in vivo models of cancer⚕️
👇Register by Aug 26
💡 buff.ly/3XkCk1h
#CancerModels #CancerModel #PreclinicalResearch #ModelOrganisms #TumourModels
18.07.2025 08:39 — 👍 0 🔁 0 💬 0 📌 0
Multi-omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine
➡️ buff.ly/yKCCKjU
#CRCSM #PrecisionMedicine
17.07.2025 09:29 — 👍 0 🔁 0 💬 0 📌 0
Endoglin mediates the tumor- and metastasis-promoting traits of stromal myofibroblasts in human breast carcinomas
👉 buff.ly/2TVz9J7
#Endoglin #BCSM #Myofibroblasts
16.07.2025 10:25 — 👍 0 🔁 0 💬 0 📌 0
🌅Our July issue is online🌄
🔖Thematic issue on ‘Liquid Biopsy and Precision Oncology’ highlighting diverse approaches utilized in liquid biopsy research & clinical applications
🔓 buff.ly/3I7WAHM
#LiquidBiopsies #ctDNA #CTC #ctDNA #CancerResearch #ClinicalOncology
15.07.2025 09:15 — 👍 0 🔁 0 💬 0 📌 0
ℹ️ Don't miss our new Commentary
Small modifier, big decision: switching to SUMO mode adds weight to cancer stemness in mammary tumors
➡️ buff.ly/ZscdSzr
#Sumoylation #CancerStemness #BCSM
14.07.2025 10:08 — 👍 0 🔁 0 💬 0 📌 0
EMT-associated bias in the Parsortix® system observed with pancreatic cancer cell lines
🔦 buff.ly/39cTLtl
🖊️ @KathleenClaes1 @KrisGevaert_VIB
#CTCs #LiquidBiopsy
11.07.2025 09:47 — 👍 1 🔁 0 💬 0 📌 0
We can't believe #FEBS2025 is over - we are still hyped!
🤯Excellent line-up of speakers, amazing quality of science and 🔥poster presentation standards!
🤝We support researchers with fair & rigorous peer review so reach out if you have questions about publishing with us
#FEBSCongress2025
10.07.2025 08:33 — 👍 0 🔁 0 💬 0 📌 0
🌟Are you joining the FEBS Press session?
💡Did you know Editors-in-Chief of the FEBS Press journals are attending #FEBS2025?
🗣Talk to them about publishing in the not-for-profit FEBS Press journals or ask them about transformational agreements allowing you to publish for free
#FEBSCongress2025
09.07.2025 07:02 — 👍 1 🔁 0 💬 0 📌 0
🏅 Congratulations to Nils Piernitzki from INM Leibniz Institute for New Materials for winning the daily poster prize from Molecular Oncology with her poster "Artificial tumour immune microenvironments for hybrid 3D cancer cultures"
#FEBS2025 #FEBSCongress2025
08.07.2025 18:00 — 👍 1 🔁 0 💬 0 📌 0
🏅 Congratulations to Patryk Lorenc for winning the daily poster prize from Molecular Oncology with his poster "Double functionalised silk nanoparticles for the delivery of oligotherapeutics to VEGFR overexpressing tumour microenvironment cells"👏
#FEBS2025 #FEBSCongress2025
08.07.2025 15:59 — 👍 1 🔁 0 💬 0 📌 0
Day 2 of the #FEBSCongress2025! We were happy to hear from our Section Editors on:
Cancer metabolism & anti-tumour immunity by Prof Ricci
Did you know that low-protein diet can modulate cancer progression?
The epigenetic code in autophagy & cancer by Prof Baek
Have you heard about oncoautophagy?
06.07.2025 17:03 — 👍 0 🔁 0 💬 0 📌 0
🏅 Congratulations to Annamaria Antona for winning the daily poster prize from Molecular Oncology with her poster "Adipose derived mesenchymal stem cells drive endometrial progression by establishing protumourigenic metabolic interactions with cancer cells"
#FEBS2025 #FEBSCongress2025
06.07.2025 14:00 — 👍 2 🔁 0 💬 0 📌 0
🚄En route to #FEBS2025
✅If you're joining us in Istanbul, make sure you check out the FEBS booth to get the latest information on travel grants and fellowships!
📝You can also talk to the Molecular Oncology team for your next paper or ask any questions about publishing
#FEBSCongress2025
05.07.2025 09:32 — 👍 1 🔁 0 💬 0 📌 0
🧪 Targeting carbonic anhydrase IX/XII prevents the anti-ferroptotic effect of stromal lactic acid in prostate carcinoma
👉 buff.ly/3vJliyq
🥼 @ElisaPardella @UNI_FIRENZE
#Ferroptosis #LacticAcid #ProstateCancer #CAFs #CarbonicAnhydrase
04.07.2025 10:05 — 👍 0 🔁 0 💬 0 📌 0
Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management
➡️ buff.ly/ATJrUCp
#Chemokine #CCR5 #BCSM
🖊️ @hkiaris1 @Bernardneuro
03.07.2025 08:48 — 👍 0 🔁 0 💬 0 📌 0
😔 Feeling the #EACR2025 Congress blues?
📣 Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’ can be browsed online!
🔎 Find them here
👉 buff.ly/sV3HCkW 🔓
#EACR2025 #EACR #CancerResearch #CancerBiology #CancerResearchers
02.07.2025 09:42 — 👍 0 🔁 0 💬 0 📌 0
A nucleotide-independent, pan-RAS-targeted DARPin elicits anti-tumor activity in a multimodal manner
🔦 buff.ly/EVTr8a8
#DARPin #DrugDevelopment #CancerTherapy
01.07.2025 10:20 — 👍 0 🔁 0 💬 0 📌 0
📣 New Method paper!
Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing
👉 buff.ly/x2AGPRI
#EpCAM #LungCancer #PleuralEffusion
30.06.2025 09:31 — 👍 0 🔁 0 💬 0 📌 0
Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer
👉 buff.ly/ikXlqbh
#ViralMimicry #Inflammation #HGSOC #Retroelements
27.06.2025 09:12 — 👍 0 🔁 0 💬 0 📌 0
Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models
➡️ buff.ly/uWXTu0R
#Cytomegalovirus #ProstateCancer #AntiviralTherapy
26.06.2025 09:09 — 👍 0 🔁 0 💬 0 📌 0
ℹ️ New Commentary now online
Beyond cytotoxic T cells: reprogrammed regulatory T cells help facilitate response to dual checkpoint blockade
💡https://buff.ly/fZq4ETw
🖊️ @BcellBruno @tonyrcillo
#CheckpointBlockade #regulatoryTcells #Tcells #Tregs #Immunotherapy #ImmunoOncology
25.06.2025 09:03 — 👍 0 🔁 0 💬 0 📌 0
⚠️Did you know?
📣Molecular Oncology is an affiliate journal with Review Commons, meaning #ReviewedPreprints can be transferred directly to the journal for editorial consideration without restarting #PeerReview
20.06.2025 09:51 — 👍 0 🔁 0 💬 0 📌 0
📢Call for papers
📭Submit your latest research in the field of #CancerImmunology #ImmunoOncology #ImmunoOnc
➡️In conjunction with @EACRnews
➡️Format: Research Article, Short Report or Method
➡️Details buff.ly/ZDb3rO0
19.06.2025 09:45 — 👍 1 🔁 0 💬 0 📌 0
📣 Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’ are now available online!
🔎 Find them here
👉 buff.ly/a3PQo3N 🔓
#EACR2025 #EACR #CancerResearch #CancerBiology #CancerResearchers
17.06.2025 09:58 — 👍 1 🔁 0 💬 0 📌 0
🌤️Our June issue is out ⛱️
❗ Don't miss the new Policy Article by Anton Berns et al on improving access to affordable cancer therapies and the EACR Viewpoint by Marta Puyol on enhancing patient engagement in cancer research
🔓 buff.ly/JO39erm
13.06.2025 10:25 — 👍 0 🔁 1 💬 0 📌 0
Unraveling LINE-1 retrotransposition in head and neck squamous cell carcinoma
➡️ buff.ly/9WIHa3P
🥼 @mgallardogomez @ramongescudero @MobileGenomes
#Retrotransposition #HNSCC #LINE1
12.06.2025 09:48 — 👍 0 🔁 0 💬 0 📌 0
The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl-xL or Mcl-1 in ovarian cancer
👉 buff.ly/Yt7gh6A
#HDACi #Belinostat
#OvarianCancer #CellDeath
11.06.2025 09:43 — 👍 1 🔁 0 💬 0 📌 0
Our goal is to understand how host niches, epi/genetics, aging, lifestyle and treatments influence residual cancer dormancy to detect, prevent and treat cancer relapse
https://montefioreeinstein.org/cancer/research/cdi
Scientific Coordinator @ National Center for Tumor Diseases (NCT) Heidelberg
Operational Board Member @ Cancer Core Europe
MSCA Postdoc fellow, Van Breusegem Lab, Oxidative Stress Signalling. VIB-UGent Center for Plant Systems Biology
Assoc Prof Oxford MD PhD. Oncology, early phase trials, tumour microenvironment #womenInSTEM #immunology
We fund cutting-edge scientific research across multiple Branches and Centers to better understand cancer and eliminate the suffering caused by the disease.
The Nuffield Department of Medicine (NDM) at the University of Oxford has a global reach and significant breadth in terms of capabilities and capacity. Find out more at http://www.ndm.ox.ac.uk
noncoding RNA, chromatin and cancer researcher
Director of DNA and RNA Medicine Division @CIMA_unav
Pamplona, Spain
ERC awardee. Music lover (bad violin player) and mother
Making life beyond cancer a reality. fredhutch.org
Teif lab at the University of Essex. We work on gene regulation in chromatin and applications to liquid biopsies, using approaches of genomics, biophysics and bioinformatics. Our focus is nucleosomics, TF binding, CTCF, cfDNA. https://generegulation.org
Scientist in the Department of Molecular Biology at UTSW/HHMI. We study post-transcriptional gene regulation & noncoding RNAs in normal physiology and disease.
https://labs.utsouthwestern.edu/mendell-lab
https://www.hhmi.org/scientists/joshua-t-mendell
PhD student @ Columbia University
Group leader at @CRGenomica and @icreacommunity, interested in understanding the role of chromatin organization/function in stem cell biology and in disease.
You're twisting my melon man
Opinions will change over time
PI Ben-Gurion University of the Negev
barakrotblat.wixsite.com/rotblatlab
Conferences can be like this https://youtu.be/n8S13FQ8g0o?si=6wzd0DvkaMUQMAdp
RNA aficionado, cancer researcher, nucleic acid quantification expert, professor at Ghent University and co-founder of pxlence and InActiv Blue
Director, Computational Biology. [nrobine]@nygenome[.org] RNA-Seq / Cancer Genomics / anything NYC / mostly in English, sometimes in French. #NoPasaran
Institute for Medical and Data Ethics
@MedicalFacultyHeidelberg @HeidelbergUniversity
Section for Translational Medical Ethics
@UKHD @NCT-Heidelberg @DKFZ
#ethics #medicalethics #bioethics #clinicalethics #researchethics #publichealthethics
